{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:18:19Z","timestamp":1783131499590,"version":"3.54.6"},"reference-count":45,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T00:00:00Z","timestamp":1128643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunology"],"published-print":{"date-parts":[[2006,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The effector CD8<jats:sup>+<\/jats:sup> T cells recognize major histocompatibility complex (MHC) class I binding altered self\u2010peptides expressed in tumour cells. Although the requirement for CD4<jats:sup>+<\/jats:sup> T helper type 1 (Th1) cells in regulating CD8<jats:sup>+<\/jats:sup> T cells has been documented, their target epitopes and functional impact in antitumour responses remain unclear. We examined whether a potent immunogenic peptide of <jats:italic>Mycobacterium tuberculosis<\/jats:italic> eliciting Th1 immunity contributes to the generation of CD8<jats:sup>+<\/jats:sup> T cells and to protective antitumour immune responses to unrelated tumour\u2010specific antigens. Peptide\u201025, a major Th epitope of Ag85B from <jats:italic>M. tuberculosis<\/jats:italic> preferentially induced CD4<jats:sup>+<\/jats:sup> Th1 cells in C57BL\/6 mice and had an augmenting effect on Th1 generation for coimmunized unrelated antigenic peptides. Coimmunization of mice with Peptide\u201025 and ovalbumin (OVA) or Peptide\u201025 and B16 melanoma peptide [tyrosinase\u2010related protein\u20102 (TRP\u20102)] for MHC class I led to a profound increase in CD8<jats:sup>+<\/jats:sup> T cells specific for OVA and TRP\u20102 peptides, respectively. This heightened response depended on Peptide\u201025\u2010specific CD4<jats:sup>+<\/jats:sup> T cells and interferon\u2010\u03b3\u2010producing T cells. In tumour protection assays, immunization with Peptide\u201025 and OVA resulted in the enhancement of CD8<jats:sup>+<\/jats:sup> cytotoxic cell generation specific for OVA and the growth inhibition of EL\u20104 thymoma expressing OVA peptide leading to the tumour rejection. These phenomena were not achieved by immunization with OVA alone. Peptide\u201025\u2010reactive Th1 cells counteractivated dendritic cells in the presence of Peptide\u201025 leading them to activate and present OVA peptide to CD8<jats:sup>+<\/jats:sup> cytotoxic T cells.<\/jats:p>","DOI":"10.1111\/j.1365-2567.2005.02262.x","type":"journal-article","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T14:51:05Z","timestamp":1128696665000},"page":"47-58","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Augmented induction of CD8<sup>+<\/sup> cytotoxic T\u2010cell response and antitumour resistance by T helper type 1\u2010inducing peptide"],"prefix":"10.1111","volume":"117","author":[{"given":"Takeshi","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichiro","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruyuki","family":"Ariga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Kariyone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Takatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,10,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.12.040194.002005"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(01)01896-8"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0502261"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60657-0"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60575-1"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60778-6"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60294-8"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80028-X"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1150"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(98)80228-8"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/35077246"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.5.753"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.251547298"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.25.11810"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(97)80053-2"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.8.1163"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.4049\/jimmunol.125.6.2367","article-title":"Augmented induction of tumor\u2010specific resistance by priming with Mycobacterium tuberculosis (TBC) and subsequent immunization with PPD\u2010coupled syngeneic tumor cells","volume":"125","author":"Takatsu K","year":"1980","journal-title":"J Immunol"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.12.4234"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4049\/jimmunol.126.2.659","article-title":"Functional characterization of the killer\u2010helper factor responsible for the induction of cytotoxic T lymphocytes from thymocytes, and evidence for the nature of this factor as distinct from T cell\u2010replacing factor (TRF) in regard to B cell triggering","volume":"126","author":"Hamaoka T","year":"1981","journal-title":"J Immunol"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/9.2.227"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1128\/IAI.67.9.4312-4319.1999","article-title":"Identification of amino acid residues of the T\u2010cell epitope of Mycobacterium tuberculosis\u03b1 antigen critical for V\u03b211+ Th1 cells","volume":"67","author":"Kariyone A","year":"1999","journal-title":"Infect Immun"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxg115"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5769(02)00209-6"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh170"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.4049\/jimmunol.159.3.1418","article-title":"Suppression of concanavalin A\u2010induced hepatitis in IFN\u2010\u03b3\u2013\/\u2013 mice, but not in TNF\u2010\u03b1\u2013\/\u2013 mice. Role for IFN\u2010\u03b3 in activating apoptosis of hepatocytes","volume":"159","author":"Tagawa Y","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.2.951"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.9.5018"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.1.65"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.155.3.768"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830171109"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/31002"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/30989"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/30996"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2392683"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/14058"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01911"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01912"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh184"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.5.617"},{"key":"e_1_2_6_41_2","first-page":"1269","article-title":"Genetic control of hapten\u2010reactive helper T\u2010cell responses and its implications for the generation of augmented antitumor cytotoxic responses","volume":"74","author":"Mizushima Y","year":"1985","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.3.1558"},{"key":"e_1_2_6_43_2","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.4049\/jimmunol.161.10.5133","article-title":"Passive but not active CD8+ T cell\u2010based immunotherapy interferes with liver tumor progression in a transgenic mouse model","volume":"161","author":"Romieu R","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200106)31:6<1780::AID-IMMU1780>3.0.CO;2-I"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20012100"},{"key":"e_1_2_6_46_2","first-page":"3012","article-title":"Phase I trial of a melanoma vaccine with gp100 (280\u2013288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes","volume":"7","author":"Slingluff CL","year":"2001","journal-title":"Clin Cancer Res"}],"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2567.2005.02262.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T18:04:05Z","timestamp":1697220245000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2567.2005.02262.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,25]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.1111\/j.1365-2567.2005.02262.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2567.2005.02262.x","archive":["Portico"],"relation":{},"ISSN":["0019-2805","1365-2567"],"issn-type":[{"value":"0019-2805","type":"print"},{"value":"1365-2567","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,25]]},"assertion":[{"value":"2005-10-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}